An app to treat children with attention-deficit hyperactivity disorder (ADHD) developed by Akili has been made available ahead of its FDA approval, under an agency scheme to speed up access to digital therapies during the coronavirus pandemic.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,